1-7 of 7
Matthew J. Matasar
Close
Sort by
Journal Articles

Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP

Clinical Trials & Observations
Kurt S. Bantilan, Alexandra N. Smith, Matthew J. Maurer, Julie Teruya-Feldstein, Matthew J. Matasar, Alison J. Moskowitz, David J. Straus, Ariela Noy, M. Lia Palomba, Steven M. Horwitz, Paul A. Hamlin, Carol S. Portlock, James R. Cerhan, Thomas M. Habermann, Gilles A. Salles, Grzegorz S. Nowakowski, Craig H. Moskowitz, Andrew D. Zelenetz
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2172–2181.
https://doi.org/10.1182/bloodadvances.2023011408
Published: 2024
Includes: Supplemental data
Journal Articles

TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy

William T. Johnson, Nivetha Ganesan, Zachary D. Epstein-Peterson, Alison J. Moskowitz, Robert N. Stuver, Catherine R. Maccaro, Natasha Galasso, Tiffany Chang, Niloufer Khan, Umut Aypar, Natasha E. Lewis, Andrew D. Zelenetz, M. Lia Palomba, Matthew J. Matasar, Ariela Noy, Audrey M. Hamilton, Paul Hamlin, Philip C. Caron, David J. Straus, Andrew M. Intlekofer, Connie Lee Batlevi, Anita Kumar, Colette N. Owens, Craig S. Sauter, Lorenzo Falchi, Jennifer K. Lue, Santosha A. Vardhana, Gilles Salles, Ahmet Dogan, Nikolaus D. Schultz, Maria E. Arcila, Steven M. Horwitz
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5172–5186.
https://doi.org/10.1182/bloodadvances.2023009953
Published: 2023
Includes: Supplemental data
Journal Articles

Retrospective characterization of nodal marginal zone lymphoma

Robert Stuver, Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip C. Caron, Ahmet Dogan, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paul A. Hamlin, Steven M. Horwitz, Brandon S. Imber, Andrew M. Intlekofer, William T. Johnson, Niloufer Khan, Anita Kumar, Oscar B. Lahoud, Jennifer Kimberly Lue, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, Colette N. Owens, M. Lia Palomba, Heiko Schöder, Santosha A. Vardhana, Joachim Yahalom, Andrew D. Zelenetz, Gilles Salles, David J. Straus
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4838–4847.
https://doi.org/10.1182/bloodadvances.2022009587
Published: 2023
Includes: Supplemental data
Journal Articles

Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data

Clinical Trials & Observations
Laurie H. Sehn, Mark Hertzberg, Stephen Opat, Alex F. Herrera, Sarit Assouline, Christopher R. Flowers, Tae Min Kim, Andrew McMillan, Muhit Ozcan, Violaine Safar, Gilles Salles, Grace Ku, Jamie Hirata, Yi Meng Chang, Lisa Musick, Matthew J. Matasar
Journal: Blood Advances
Blood Adv (2022) 6 (2): 533–543.
https://doi.org/10.1182/bloodadvances.2021005794
Published: 2022
Includes: Supplemental data
Journal Articles

Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma

Clinical Trials & Observations
Parastoo B. Dahi, Jasme Lee, Sean M. Devlin, Josel Ruiz, Molly Maloy, Carlos Rondon-Clavo, Erica Petrlik, Roni Tamari, Gunjan Shah, Michael Scordo, Matthew J. Matasar, Paul A. Hamlin, Esperanza Papadopoulos, Ann A. Jakubowski, Miguel-Angel Perales, Craig H. Moskowitz, Craig S. Sauter, Sergio A. Giralt
Journal: Blood Advances
Blood Adv (2021) 5 (12): 2608–2618.
https://doi.org/10.1182/bloodadvances.2020004167
Published: 2021
Includes: Supplemental data
Journal Articles

Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue

Clinical Trials & Observations
Erel Joffe, Yan Leyfman, Esther Drill, Sridevi Rajeeve, Andrew D. Zelenetz, M. Lia Palomba, Craig H. Moskowitz, Carol Portlock, Ariela Noy, Steven M. Horwitz, John F. Gerecitano, Alison Moskowitz, Paul Hamlin, Matthew J. Matasar, Anita Kumar, Connie L. Batlevi, Anas Younes, David J. Straus
Journal: Blood Advances
Blood Adv (2021) 5 (2): 345–351.
https://doi.org/10.1182/bloodadvances.2020003213
Published: 2021
Journal Articles

Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma

Clinical Trials & Observations
Anita Kumar, Santosha Vardhana, Alison J. Moskowitz, Pierluigi Porcu, Ahmet Dogan, Jason A. Dubovsky, Matthew J. Matasar, Zhigang Zhang, Anas Younes, Steven M. Horwitz
Journal: Blood Advances
Blood Adv (2018) 2 (8): 871–876.
https://doi.org/10.1182/bloodadvances.2017011916
Published: 2018
Includes: Supplemental data